Electrical stimulation for delivery of biochemical agents such as genes, proteins and RNA molecules amongst others, holds great potential for controlled therapeutic delivery and in promoting tissue regeneration. Electroactive biomaterials have the capability of delivering these agents in a localized, controlled, responsive and efficient manner. These systems have also been combined for the delivery of both physical and biochemical cues and can be programmed to achieve enhanced effects on healing by establishing control over the microenvironment. This review focuses on current state-of-the-art research in electroactive-based materials towards the delivery of drugs and other therapeutic signalling agents for wound care treatment. Future directions and current challenges for developing effective electroactive approach based therapies for wound care are discussed.
Introduction
Wound healing is a coordinated process relying on precise spatiotemporal mechanisms of action. Significant progress has been made to identify specific signals (e.g. small molecules, cytokines, growth factors, RNA interface, genes, cell-based therapies) of therapeutic benefit [1, 2] . To this end, there is great interest in applying these mechanisms to enhance and accelerate wound healing and enable tissue repair that otherwise could not occur naturally. However, despite the advances made in the field, wound regeneration continues to be a constant challenge for health-care professionals.
Injuries to healthy tissues are known to give rise to localized electric fields that play a key role in the process of healing of these wounded tissues [3] . Both delivery of therapeutic drugs and electrical stimulation therapies have been identified as essential tools to enhance the process of wound healing [4] [5] [6] . Advances in the delivery systems of these therapeutics have been reviewed [7, 8] , however, establishing control over their release and stimulus is challenging. To this regard, electroactive biomaterials are gaining prominence and are the focus of the current review in the field of therapeutics for drug delivery and tissue regeneration.
Electroactive biomaterials and their modes of action
The family of electroactive biomaterials ( Fig. 1) is considered a new generation of smart materials that allow direct delivery of electrical signals by control over the electric potential. They have the advantage that they can be combinatorially active (i.e. stimulatory to the tissues as well as triggering controlled/responsive release of therapeutics). Such systems provide clinicians and scientists with an alternative delivery mechanism in wound care, facilitating in turn the development of new therapeutic approaches for patients.
Electroactive biomaterials have the potential to have their chemical, electrical and physical properties tailored for the specific needs of their application. The family of electroactive biomaterials includes conductive polymers, piezoelectrics, photovoltaic materials, and electrets.
Conductive polymers
Conductive polymers (CPs) are organic polymers that offer a compromise between the good electrical, magnetic and optical properties of metals and the ease of processing and mechanical properties associated with polymers [9] [10] [11] [12] . Currently there are over 25 conductive polymer systems [9, 10] . The most widely researched of these are polypyrrole (PPy), poly(3,4-ethylenedioxythiophene) (PEDOT) and polyaniline (PANI) [9, 10] .
CPs are electrically conductive due to the ease with which electrons jump within and between their polymer chains [13] . A key factor in this conductivity is the "dopant" [13] [14] [15] . Conductive polymers are synthesized in an oxidized state and require a negatively charged (anion) molecule -the dopant -to enter the polymer so that the polymer backbone can be stabilized [16] . This dopant is what introduces a charge carrier into this system by removing or adding electrons from/to the polymer chain, creating polarons or bipolarons. Polarons and bipolarons are loosely held, localized electrons that are surrounded by a distortion in the crystal lattice. When an electrical potential is applied, the backbone is disrupted by the movement of the dopant molecules in or out of the polymer. This allows electrical charge to be passed through a polymer in the form of the above-mentioned polarons and bipolarons [13] [14] [15] 17] . Many of the CPs have been shown to be cell friendly, supporting the growth of a large number of cell types and displaying good biocompatibility in animal models [13, [18] [19] [20] [21] [22] . For example, PPy has been demonstrated to support the growth, adhesion and differentiation of neural [23, 24] , glial [25] , endothelial [26, 27] and bone cells [18, 28] , fibroblasts [29] , keratinocytes [29] and mesenchymal stem cells [30] . Similarly, PEDOT has been demonstrated biocompatible with neural [31] and neuroblastoma cells [32] , epithelial cells [13] , and the L929 [33] and NIH3T3 fibroblasts cell lines [13] .
Piezoelectric materials
Since their discovery in 1880 by the Curie brothers, piezoelectric materials have found applications in different fields such as energy harvesting, biomedical instrumentation, tissue engineering and drug delivery [34] [35] [36] [37] [38] [39] . These materials are capable of generating charges (i.e. electrical output) in response to applied mechanical deformations (i.e. direct effect) and also deform in response to applied electric fields (i.e. converse effect) [38] . This effect is attributed to their non-centrosymmetric crystal/chemical structure, which is deformed on application of a force resulting in formation of a net dipole leading to electric polarization [40] . Though these materials are inherently piezoelectric, the dipoles are randomly oriented in the bulk of the material and need to be rearranged to enhance their piezoelectric feature. The procedure used to carry out such rearrangement is termed poling and involves the application of a high electric field at a specific temperature followed by cooling the material under the same electric field [35] . A schematic of the poling procedures and representation of direct and converse piezoelectric effects is shown in Fig. 2 . Piezoelectric materials can be based on synthetic polymers or ceramics, naturally occurring materials or hydrogel systems (a list of piezoelectric materials is shown in Table 1 ). These materials can be fabricated into macro-, micro or nano-level structures and consequently be used for efficient and controlled release of drugs and therapeutic agents. The potential applications of these materials in the . Photovoltaic mechanism: a) conventional photovoltaic cell where electron-hole pairs migrate to opposite electrodes upon photo stimulation and electric current is produced; b) photovoltaic cells depicting the schematics of a planar heterojunction, a blended bulk heterojunction and an ordered heterojunction; c) model of a conceptual nanoscopic photovoltaic device depicting realistic and optimal design dimensions.
field of medicine require considerable attention of the scientific community.
Electrets
Electrets are dielectric materials capable of retaining quasi permanent electrical charge or dipole polarization which is not destroyed over time [41, 42] . The process of fabricating electrets is similar to the poling process of piezoelectric materials by which the material is charged at a constant voltage. A dielectric material is sandwiched between electrodes, heated to softening temperature and a direct current electric field is applied and maintained while the material is cooled to room temperature [43] . Based on the type of charges developed on the surface of the electret, they can be classified into two types (i) homocharged and (ii) heterocharged [44] . The different types of electrets and the charges associated with their formation are shown in Fig. 3 .
Photovoltaic materials
Photovoltaics (PV) is the process of converting light into electrical power by using semiconductor materials that are able to absorb and trap light while exciting a charge carrier to a higher energy state, creating an electron flow: light absorption creates electron-hole pairs, and electrons and holes respectively migrate to opposite electrodes [45] (Fig. 4a) .
Essentially, a PV device (Fig. 4a ) consists of two regions, an n-type dope region and a p-type dope region, respectively featuring an excess of electrons and a deficit of electrons (i.e. holes), and the presence of contacts [46, 47] . When both components come into contact, the excess of electrons flow from the n-type dope region into the p-type dope region, creating an electric field in between.
While PV devices can be found in many forms, these can be classified into three main types. The simplest PV device consists of an electron donor and an electron acceptor sandwiched together into a thin film (single or double layer) for the charge carrier to be allowed to diffuse through the junction (Fig. 4b) [48] . However, the thinner the film the less amount of light it can entrap. The previous shortcoming can be addressed by mixing the electron donor and electron acceptor components into a blend (Fig. 4b) [49] , enhancing carrier diffusion. These PV devices generally consist of composite blends mixing semiconductor nanoparticles with conjugated polymers [50] [51] [52] [53] , where one functions as an electron donor and the other as an electron acceptor [51] . Blending semiconductor nanoparticles with conjugated polymers combines the easy processability and low cost of the polymer with the high charge mobility of the nanoparticle, which may include spherical, rod-like or branched organic and inorganic particles such as CdSe, ZnO, PbS, fullerene derivatives or single-walled nanotubes [54] [55] [56] . The performance of the composite can be enhanced in terms of light absorbance, charge separation or charge transport, which depends on the choice of the conjugated polymer and the processing condition [57, 58] . However, the size and shape of the nanoparticle is also key: branched morphologies exhibit higher efficiencies compared to the use of nanorods or quantum dots [49] , and small dimensions (i.e. large surface area to volume ratio) improve energy absorption and emission owning to high optical density [51] . An alternative to the PV blend device format is for a conjugated polymer to be inserted into a porous inorganic network as an ordered heterojunction-like structure (Fig. 4b) [59] . Electron transport is facilitated this way as the interface between the polymer and the inorganic component is mainly governed by the dimension of the nanostructure particle, these interfaces can be chemically controlled to assist charge separation or block charge recombination across the donor-acceptor interface [59] .
Electroactive biomaterials as drug delivery systems

Electrochemically controlled drug delivery based on CPs
CPs have been investigated as potential candidates for drug delivery systems since as early as the 1980s, when Zinger and Miller demonstrated that glutamate and ferrocyanide can be released from polypyrrole films through the application of an electric potential [60] .
Drug loading and release mechanisms for CPs
Drug delivery systems based on CPs exploit the polymers' ability to be electrically switched between an oxidized and a reduced state, resulting in the uptake or expulsion of charged molecules from the bulk of the polymer [61] [62] [63] . A wide range of solutions have been developed based on this phenomenon for the loading and controlled delivery of both positively and negatively charged and neutral drug compounds [61, [64] [65] [66] . Amongst others, dexamethasone [67] , heparin [68] , dopamine [69] , naproxen [70] , neutrophin-3 [71] , and neural growth factor (NGF) [22, 31] have all been successfully bound and released from conductive polymers.
Loading of the drug compound can be performed in a number of ways depending on the type of the drug (Fig. 5 ): small anionic compounds can be loaded through one-step immobilization (Fig. 5a) , as dopants during the polymer synthesis process [64, 72, 73] . This is the simplest method; however, if the drug molecule interferes with the polymerization process, the created material will suffer from low conductivity and drug loading capacity, and unfavourable mechanical properties [64] .
This limitation of the one-step methods can be overcome through the use of the more elaborate three-step method [11, 64, 66, 73] . The three-step method (Fig. 5b) separates the synthesis and drug loading processes, allowing both to be carried out with optimal parameters. First, the polymer is synthesized using an ideal anionic "primary" dopant. Following synthesis, a reducing potential is applied flushing out the primary dopant. Afterwards, the desired medicinal compound can be incorporated into the polymer by reversing the potential. A great benefit of this method is its application to the loading of large anionic compounds. However, if the process of removing the dopant and incorporating the drug are inefficient, drug loading capacity will be limited [64] .
In a comparison of the one-step and three-step methods, post-synthesis loading has been shown to produce the highest loading for ciprofloxacin, while incorporation during synthesis provided the highest loading for quercetin [73] . This difference was due to quercetin crystallizing on the surface of the polymer when introduced post-synthesis and the subsequent matrix conditioning steps removing it [73] . Cationic drugs require a modified version (Fig. 5c ) of the three-step method [62, 66, [72] [73] [74] . Here, the polymer is synthesized with a large primary anionic dopant that, due to its size, is immobilized inside the polymer matrix during synthesis. Following this, the application of a reducing potential to the polymer results in the positively charged drug entering the material to maintain electroneutrality. This method was successfully applied to the loading and release of dopamine [69] and chlorpromazine [63] , using poly(styrene-sulfonate) (PSS) and melanin as the dopant respectively. It has also been adapted to the loading of the neutral drug, Nmethylphenothiazine, relying on the hydrophobic-hydrophilic interaction between the drug and an anionic "host" molecule, β-cyclodextrins [75] .
Anionic drugs can be released with the application of a reducingnegative -potential, while cations can be unbound by either the removal of a negative potential or the application of an oxidizing -positivepotential [66, 76, 77] . The required voltage, generally speaking, depends on the reduction potential of the polymer [78] . In published studies, reported applied values range between 0.6 and 2 V [61, 62, 72, [79] [80] [81] . A higher potential results in faster release [82] [83] [84] . For example, −2 V releases fluorescein from nanoporous PPy films 3-4 times faster than −1.5 V [80] . A similar trend was observed during the co-release of fluorescein and dexamethasone from PPy sponges, where −2 V produced a two-fold release rate compared to −0.5 V [81] . On the other hand, too high potentials can result in the destruction of the bound drug compound through oxidation or hydrolysis, as it was observed in the case of dopamine above − 0.6 V [62] , and neural growth factor above 3 V [85] . Switching to the opposite polarity can help maintain the drug inside the polymer matrix by counteracting diffusion [82, 84, 86, 87] . However, this does not apply to every case as during the release of the cationic compound acetylcholine from PEDOT:PSS, both + 1 V and −1 V produced the same release profile [72] .
The method of delivering the potential is also important: different drug release profiles have been observed depending on whether pulsed potential, pulsed current or cyclic voltammetry was applied [65] . In another study, potentiodynamic stimulation generated higher drug release efficiency than potentiostatic stimulation [64] . Cyclic voltammetry has been stated as the most efficient method for stimulation [11] , also allowing greater control over release speed through the setting of different scan rates [88] . Beyond the applied electrical potential, stimulation time [82, 84, 86, 87] ; polymer film roughness, porosity, density and thickness [11, 61, 65, 66, 83, 90] ; the dopant [83, 86] ; and temperature [82, 91] are known to affect and allow greater control over optimising the release profile.
The chemical environment can also have a profound effect. The release of insulin from PPy-gold nanoparticle composites has been observed to be pH-sensitive with the release slowing down at low pH [84] . The co-application of an electric potential further increased this sensitivity [84] . A strange relationship was noted between pH and the effect of the electric potential in the case of safranin release from PPypoly-(acrylic acid) (PPy-PAA) hydrogel composites. At pH 6.4, a potential of +0.4 V enhanced release, while −0.4 V helped block diffusion. On the other hand, at pH 3.8 the exact opposite was seen with −0.4 V promoting release, and + 0.4 V preventing it [92] . In contrast to these pH dependent responses, the release of aspirin from PPy-montmorillonite composites was insensitive to whether it was performed at pH 3.4, 7.4 or 11.4 [93] . Chemistry alone can be used to propagate the release of the drug compounds. Hydrazine and alkaline medium was able trigger the release of adenosine triphosphate (ATP) from PPy membranes, albeit to a lesser extent compared to an electrical potential [94] .
Polypyrrole (PPy) and poly-(3,4-ethylenedioxythiophene) (PEDOT)
PPy and PEDOT are members of the polyheterocycles family of conductive polymers, and have been almost predominantly the CP of choice for drug delivery applications [13, 84, 95, 96] . PPy and PEDOT films have been used, for example, for the release of chlorpromazine [63] , dexamethasone [67, 78, 97] , neurotrophin-3 [65, 98, 99] , risperidone [87,100, 101], brain-derived neurotrophic factor (BDNF) [102] , adenosine triphosphate (ATP) [94] , dopamine [62] , acetylcholine [72] , methotrexate [82] , betulin [103] , quercetin and ciprofloxacin [73] . However, this section will focus on the more advanced drug delivery solutions that have been developed in recent years based on these two polymers.
For many applications, simple CP films alone do not provide sufficient drug storage capacity [88] . The use of micro-and nanostructures can provide a solution to this by offering greater volume and surface area for drug binding. One such structure was created from PPy nanowires, where the micro-and nanogaps between the wires served as reservoirs for the binding of ATP and dexamethasone [88] . Micro-and nano-tubes consisting of a drug laden inner core of bacterial cellulose [79] , PLLA or poly(lactide-co-glycolide) (PLGA) [104] and an outer shell of PEDOT have also been fabricated.
Sponge-like structures can be created by polymerising PPy around sacrificial nano-or microbeads that are then later removed. Such nanostructures have been used for the release of rhodamine B [105] , dexamethasone [81, 106] , fluoroscein [80, 81] , chlorpromazine [91] , and risperidone [90] . The nanoporous PPy structure provided a capacity nine times greater compared to conventional PPy films in the case of fluorescein [80] , and four times greater in case of risperidone [90] . Brush-like structures were generated by depositing PPy on top of aligned carbon nanotube surfaces for the delivery of neurotrophin-3, possessing a surface area ten times higher than a film [107] . A similar approach was used for the enhanced binding and release of dexamethasone and penicillin [108] . A petal-like structure was achieved through polymerising PEDOT on top of single-wall carbon nanotubes immobilized on a gold surface [109] . Compared to neat PEDOT this material possessed improved conductivity, charge capacity and drug release rate [109] . Furthermore, it was able to resist three times longer the degradation effects (e.g. delimitation and cracking) of cycling the CP through its redox states during electrical stimulation [109] . Carbon nanotubes have been used in an alternative approach by Luo et al. as containers for drug molecules [110] : PPy was electropolymerized on the open ends of dexamethasone loaded carbon nanotubes, providing a seal on the ends of the nanotubes that could be opened with electrical stimulation [110] .
Nanocomposites offer an additional solution to improving drugloading capacity. Graphene oxide (GO) has been successfully combined with PPy to generate a composite material with twice greater dexamethasone binding capacity than PPy alone, a linear release profile up to 400 stimulations, and no passive drug diffusion [111] . GO has been used in combination with PEDOT to deliver dexamethasone in a smart coating for orthopaedic implants [112] . An interesting new approach in CP composites is the use of clay particles, such as palygorskite [113] and montmorillonite [93] , that lend their large specific surface area to the composite material.
PPy and PEDOT have been combined with hydrogels, that are themselves important drug delivery tools, made from PAA [92, 114] , poly(lactic-co-glycolic acid)-co-poly(ethylene glycol) (PLGA-PEG) [77] , alginate [115] , and xanthan [116] . These blends combine the high electrical conductivity and electrically and chemically switchable properties of CPs, with the high swelling ability, excellent small molecules diffusivity, and good biocompatibility of hydrogels [92, 114] .
Ge et al. used microfabrication to construct a PPy based microchip with 36 independent electrodes. This novel device is able to supply multiple drugs at the same time or sequentially over multiple days, while offering greater control over doses than simple PPy films [76] . The same authors have also created a very interesting self-activating system by turning the CP based drug release system into a galvanic cell. Magnesium was coated onto one side of a PPy coated porous cellulose film. Submerging the film into a NaCl solution resulted in the magnesium oxidizing, which in turn resulted in the reduction of the PPy, releasing the bound ATP [117] . This created a flexible, lightweight and partially-biodegradable device that does not require an external power source to operate [117] . Similar solutions have been developed by coating magnesium onto PPy nanowires containing ATP [118] , and depositing PEDOT/GO onto biodegradable magnesium substrate [112] .
In order to overcome limitations that might arise from limited drug loading capacity, the molecular weight of the medicinal compound, or the drug-dopant interference, a drug binding method based on biotinstreptavidin coupling has been proposed [85, 119] . This technique was successfully used for the binding and release of molecules both directly attached to the polymer [85] or coated on the surface of intermediating gold nanoparticles [119] .
Nanoparticles have also been fabricated out of CPs (Fig. 6 ). An encapsulation efficiency of 95% was achieved when loading ketoprofen inside PPy iron oxide nanoparticles [121] . PPy nanoparticles with the capability to release both at acidic and basic pH have been engineered, enabling their use in a wide range of tissue environments, including the pH 1-3 of the stomach and the pH 7-8 of the colon [122] . These PPy nanoparticles have also been immobilized in a calcium alginate hydrogel for the sustained pH dependent release of the anti-inflammatory drug piroxicam [122] . In a recent study, a targeted nanocarrier system was developed for chemotherapy, where rapamycin was bound in a liposome wall formed around PPy nanoparticles. The liposome was coated with Herceptin® (trastuzumab) that binds specifically to the HER2/ neu receptor expressed by breast cancer cells, enabling target cell specific cellular uptake. Exposing the target area/cells to an 808 nm laser heated up the particles, releasing rapamycin and triggering apoptosis [120] .
A very different drug release mechanism was engineered by Jeon et al. [123] ; instead of the electrostatic binding and release, a delivery system exploiting the mechanical swelling and contraction of PPy was fabricated. PPy pores were polymerized on top of anodized aluminium oxide membranes [123] . The PPy pores could be opened and closed through the application of an electrical potential, releasing on demand the bovine serum albumin contained in a reservoir situated on one side of the membrane [123] . The created device possessed a very fast response time in the range of 10 s, and a capacity only limited by the reservoir behind the aluminium oxide membrane [123] .
Other conductive polymers
The field of CP based drug delivery is dominated by PPy and PEDOT. However, there are examples of other CPs being applied, including degradable electroactive copolymers synthesized from oligoaniline and [88] ; b) microtubes [79] ; c) nanoporous structures [105] ; and d) nanoparticles [120] .
PEG or poly(ε-caprolactone) (PCL) blocks. The resultant materials were found to be degradable in vitro, supported the adhesion of human dermal fibroblasts, and successfully delivered dexamethasone with potential cycling between 0.7 V and −0.5 V [124] . Oligoaniline has also been combined with oligoalanine to form electroactive supramolecular polymers for the delivery of dexamethasone phosphate [125] . Poly(Nmethylpyrrolylium) poly(styrenesulfonate) was successfully used as a cation exchanger for the binding and the release of dopamine [69] . The conductive polymer poly(p-phenylenevinylene) (PPV) has been applied in combination with polyacrylamide (PAAM) to create a hydrogel with a tailorable release profile. The presence of PPV in the hydrogel delayed the release of salicylic acid in the first 3 h, and this blocking effect could be extended to above 15 h with the application of a 0.1 V anodic potential. Release could be triggered with the application of a cathodic potential, the rate increasing with greater electric field strength. The release profile could be further optimized by varying the crosslinking density, and the size of the drug and the pores in the hydrogel [126] .
Piezoelectrically active materials for drug delivery
The piezoelectric principle of some materials has been researched in the field of drug delivery; for instance, in the fabrication of micropumps to treat diseases such as diabetes, with direct effects on tissue healing [127] [128] [129] [130] [131] , or in the development of hybrid composite scaffolds made out of piezoelectrically active materials [132] [133] [134] .
Drug release mechanism on piezoelectric based materials
The use of the piezoelectric mechanism for driving micropumps for drug delivery is common due to various advantages such as low power consumption, wide range of frequency operation, a rapid signal response and the ability of piezo actuators to be integrated in microsystems with ease [135] . Micropumps are preferred drug delivery systems as they provide better control, precision, accuracy and reliability than other drug delivery methods such as oral, injectable, nanoparticle based delivery or others [136] . Primarily localized delivery of insulin in diabetic patients has been explored using micropumps alongside some other lesser researched fields [137] . A schematic of the working principle of different types of piezoelectric micropumps for drug delivery is shown in Fig. 7 .
PZT based actuators are the most commonly utilized piezomaterials over the past three decades to fabricate micropumps for controlled release of drugs [34, 136, 138] ; piezoelectric micropumps with and without valves have been studied extensively [136, 139] . In 2014, Wei et al. reported the design and fabrication of a valve-less piezoelectric micropump which was screen printed on a substrate using multiple layers of different materials [140] . These pumps printed on flexible substrates have possible applications in wearable smart fabric devices for drug/bactericide delivery. The absence of valves in the micropumps makes their design and fabrication process simpler and also, they are less prone to clogging and require lower voltages of operation [135, 140] . A drive frequency of 3 kHz was used to achieve a maximum flow rate of 38 μL/min. Different designs reported for valve-less pumps have been well optimized for higher delivery rates (i.e. flow rates) and better reliability [135, 141] . However, successful operation of valve-less micropumps depends on the efficiency of the flow rectification process of the proposed design [139] . The presence of valves in micropumps ensures precise control over the flow rate, direction and stability, and makes them more reliable than valve-less designs [142] . Modifications to different parts of the micropump such as vibrating mechanisms and valve design can be made to improve the performance [142] [143] [144] . Wang et al. proposed the use of a folding vibrator system in combination with check valves and compressible spaces [142] . A minimum stable flow rate of 160 μL/min was obtained using a low drive voltage. The study clearly suggests that highly efficient micropumps can be fabricated if proper design considerations are made. To ensure successful implantation of these micropumps, it is important to use biocompatible components to design them. However, the non-degradability of these pumps limits their use as invasive procedures may be required for implantation and removal of these pumps after the function has been served.
Advances in microfluidics and nanofabrication technologies have enabled the miniaturisation of implantable drug delivery systems [145, 146] . Piezoelectric based micropumps could be worn as dermal patches, smart wearables or implanted within the body with a power source to achieve delivery of desired drug profiles. This approach of administering drugs in a controlled manner is encouraging, with some of these implantable pumps commercially available. However, the use of drug-loaded implants/scaffolds is a more promising solution. Through the use of drug-loaded scaffolds, an efficient delivery of drugs can be ensured and the repair process enhanced due to the presence of localized electrical environments set up by the electroactive scaffolds [147, 148] . However, controlling the adsorption and release behaviour of drugs through external stimuli has been explored [149] .
Piezoelectric materials have been used to develop hybrid composite scaffolds for the release of drugs and genes [132] [133] [134] . In 2010, Ciofani et al. reported the use of BTNPs dispersions in glycol-chitosan to form complexes with a widely used chemotherapy drug, doxorubicin, to enhance its delivery to cells and improve treatment efficiency [133] . Similar to this study, Suh et al. reported on increased cellular uptake of BTNPs coated with polyethylenimine (PEI) [132] . Both studies highlight the use of BTNPs as vectors without any mentions of the role of the piezoelectric properties and their possible role in altering delivery of genes or drugs. On similar lines, a more recent study published in 2016 highlights the use of BNNTs for delivery of fluorescent probes and drugs such as curcumin, a potent anti-inflammatory, anti-microbial and anti-oxidant wound-healing agent [134] . Curcumin was shown to be entrapped within the nanotubes through characterisation by transmission electron microscopy imaging [134] . In another study, He et al. reported loading of electrospun fibrous PVDF membranes with antibacterial drug enrofloxacin for treating dermal injuries [150] . The drug release profile observed was similar to that desired for wound healing processes [150] . In this study, it was mentioned that the enrofloxacin was present in large portions on the outer surface of the fibres and diffusion was the main driving mechanism of drug release [150] . However, the contribution of the piezoelectric effect towards drug loading and release was not studied in any of these works and remains to be explored.
Electret mediated delivery of drugs
Electrets for drug delivery mainly come in the form of patches and are mainly limited to transdermal delivery. They can carry different values of surface potentials depending on the amount of surface charges retained. These can subsequently give rise to electrostatic fields and microcurrents which can assist in the process of wound healing and transdermal drug delivery (i.e. TDD, a process of administrating drugs/ therapeutic agents through intact skin) [151, 152] .
Research reported over the last two decades have shown that the electrical fields generated by electrets based on polytetrafluoroethylene (PTFE) and polypropylene (PP) are capable of altering the permeability of skin and promote transdermal delivery of drugs [152] [153] [154] (Fig. 8) . Regulation of the electret state of the skin, arrangement and fluidity of lamellar lipids and structure of proteins in the stratum corneum (the outermost layer of skin considered to be the main barrier for TDD), leading to formation of wide gaps have been shown to be the key mechanisms for improvement of TDD [152] [153] [154] [155] [156] . Cui et al. performed several studies using PP electrets prepared by film casting technique, combined with different chemical enhancers (that promote TDD by altering skin structure) for different types of drug formulations [155, 157, 158] . In one of the studies, it was observed that electrets of various surface potentials alone enhanced the permeation of meloxicam, a low molecular weight drug (b 1 kDa), more than the chemical enhancer on its own [158] . However, in case of cyclosporine A, a drug with higher molecular weight (N1 kDa), electrets alone of different surface potentials were not able to achieve similar levels of drug permeation as the chemical enhancer [157] . Similar results were obtained in a study by Murthy et al. which showed that Teflon electrets were unable to enhance delivery of high molecular weight drugs [159] . To this regard, a novel approach has been suggested by Tu et al. to address the issue of delivering high molecular weight drugs [155] . The study shows that using drug loaded N-trimethyl chitosan nanoparticles (TMC NPs) in combination with PP electret films enhances transdermal delivery of protein drugs, thanks in part to the mucoadhesive ability of chitosan to be absorbed across mucosa epithelia. The results obtained in the studies are promising, showing that the skin permeation to protein drugs and nanoparticles is increased with the increase of surface voltage of positively charged electrets, and gradually decreases with an increase of surface voltage of negatively charged electrets. However, there are factors that require optimization for success of such systems. In particular, the nature, sign and magnitude of the surface potential of the electret, the type of drugs and the type of nanoparticles are all equally important to be Fig. 8 . Transdermal drug delivery system based on electrets.
analysed [155] . Also, it is important to assure that the surface charge of the electrets is not shielded by moisture or other contaminants [159] .
Targeted drug delivery using photovoltaic materials
One of the main goals of drug delivery systems is to minimize the exposure of the drug to healthy tissues while achieving an appropriate therapeutic dosage concentration in the wound site. Photovoltaic materials have recently started to gain attention in therapeutic applications as a way to control the release of specific drugs when the charge intensity or polarity of the material changes upon external light stimulation (i.e. near infrared or laser source, 650-900 nm wavelength). This is known as photovoltaic therapy (PVT), where positively and negatively charged drugs can be loaded onto the surface of a PV device (either on n-type or p-type doped regions) by means of electrical attraction (i.e. negative or positive) and be released to target sites via electrical repulsion upon light initiation (Fig. 9 ).
To date, PV devices have not been extensively research for drug delivery applications and scarce examples are found in the literature. The proof of concept dates back to 2013 when Bhuyan et al. demonstrated that negatively charged bovine serum albumin and positively charged poly-L-lysine, attached to the positive and negative sides of a PV cell respectively, were released upon external photo stimulation [160] .
As long as the principle of photovoltaics is maintained, PV devices can be manufactured from a wide range of micro/nano mesoporous materials such as silica [161, 162] , with tuneable pore sizes, shapes and morphologies, which also provide for high drug loading capacity and manipulative surface in terms of cell-material interactions. For instance, micro-size PV cells from silica have already been manufactured, being more effective at dissipating heat when they range below the millimetre size [160] . However, the move is now focused towards developing nanoscale devices in formats other than films that could further facilitate drug delivery. For instance, photovoltaic based nanoparticle cells (NPVDs) have already been envisioned with designs theoretically functional [163] , and have been produced from silica, gold and silver materials [164] . However, it is important to target the sequestration of these NPVDs as drug carriers to the wound site (Table 2) , and an optimal size of around 6 nm (n-type thickness of 3 nm, p-type thickness of 2 nm and contact thickness of 2 nm) is required for them to be successfully used as delivery carriers to ensure maximum renal filtration. Based on the current technology, the realistic achievable NPVD size is 9 nm (n-type thickness of 5 nm, p-type thickness of 3 nm and contact thickness of 1 nm), though, with an 8 nm glomerular pore size [163] (Fig. 4c) . The activation of these NPVDs remains in the near infrared, and any drug can theoretically be transported. 3.4.1. Drug loading and release on photovoltaic based materials Two hypothetical mechanisms of action have been proposed regarding PVT, mainly drug retractability and contact to p-type region. In the drug retractability mechanism [163] (Fig. 9a) , a PV device in neutral state is coated with a positively charged drug on the p-type region. Upon stimulation, positive and negative charges form in the p-type and n-type regions respectively, and the presence of a contact in the ptype region allows positive charges to interact with the environment and repel the positively charged drug in the material. When stimulation ceases, both the p-type and n-type regions return to their neutral state attracting the drug and any other charged molecules from the environment, thus, controlling timing and duration of the drug-environment interactions in a back and forth of neutral and charging cycles and reducing the impact of any side effects. In the contact to p-type region mechanism [163] , contacts are only applied on the p-type region of the device. While contacts can be applied to both the p-type and ntype regions for higher drug capacity (i.e. positively charge drugs adsorbed onto the p-type and negatively charged drugs adsorbed onto the n-type regions), there is a chance that upon stimulation of the device the negatively and positively charged drugs will be attracted to opposite regions upon initial repulsion (Fig. 9b) . This limits drug interaction at the desired site of action, but can be easily solved by removing the contact from the n-type region so that negative charges do not interact with the environment. In this sense, higher drug delivery efficacy is achieved at the expense of a reduced drug capacity.
Metal organic frameworks as photovoltaic devices in wound care
Metal organic frameworks (MOFs) are highly porous network materials consisting of metal ions linked together by organic bridging ligands [168, 169] . MOFs were first proposed as an alternative new controlled drug delivery system back in 2004 [170] due to their combined high pore volume, regular porosity, and tuneable organic groups within the framework that allow easy modulation of the pore size and makes them more competitive as therapeutic containers [171] [172] [173] [174] [175] than conventional pore materials (Fig. 10 ). Since then, several studies on the use of MOFs as delivery vehicles of molecular therapeutics (i.e. antimicrobial metal ions [176] or homeostasis regulators such as copper [177] ) and gaseous therapeutics (i.e. nitric oxide [178] ) for skin wound treatment have emerged in the form of hydrogel systems [179] [180] [181] .
Although MOFs are mainly non-conductive, the use of structural doping or short inorganic and conjugated organic bridging ligands in their structures can extend their potential to be used as PV devices [182] [183] [184] . PV-based MOF systems have been thoroughly reviewed by Kaur et al. [185] . In this sense, there is growing interest in combining the capabilities of MOFs with the PV effect for these devices to be used as therapeutic delivery carriers to promote and enhance skin regeneration.
The stimulatory response of electroactive materials in wound healing
Electrical stimulation (ES) alone has been shown beneficial for the treatment of wounds and injuries. ES has been shown to aid the reepithelisation of skin and corneal wounds; to enhance angiogenesis; and to promote the migration of fibroblasts, keratynocytes and epithelial cells [186] [187] [188] [189] [190] [191] [192] . ES's ability to induce re-innervation [193, 194] and increase skin blood flow [195] aids in the healing of wounds. ES can show significant antibacterial effects, for example, it has been demonstrated to reduce the number of methicillin-resistant Staphylococcus aureus colonies by over 87% both in vitro and in vivo [196] . Furthermore, ES has been successfully used in the treatment of diabetic ulcers [197] ; and nerve damage in sciatic nerve [198] and spinal cord injury models [199] ; and as an osteoinductive tool in treating normal and non-union fractures, osteoporosis and osteoarthrosis [200] [201] [202] [203] [204] . ES's ability to manage pain is also an important consideration [205, 206] . Transcutaneous ES has been shown as to be a non-invasive, drug-free alternative in managing acute and chronic pain [205] , in one example reducing pain scores by 38% and drug consumption by 25% [206] .
Stimulatory response of CPs in tissue repair
The use of CPs in the treatment of injuries ranges from conduits [207] and injectable particles [208] for the repair of nerve damage, to tissue engineered solutions [209] and biosensing devices [210] . Most of the wound healing techniques developed from CPs utilize their antibacterial properties [211] [212] [213] [214] [215] . Wound covering fabrics produced from PPy and PANI have been shown to decimate populations of E. coli, E. agglomerans, B. subtilis and S. aureus [211, 214, 215] . The antibacterial effect of CPs have been attributed to the excessive positive charge and oxidizing potential of the polycationic backbone of the polymer disrupting the cell wall and interfering with bacterial respiration; and to the electron donor-acceptor character of CPs hindering bacterial adhesion and blocking biofilm formation [211, 213, 214] . The effect has also been demonstrated to be a result of the polymer itself, and not due to the oxidizing agent or dopant used during the synthesis of the CP [213] . Their already strong bactericidal effect has been enhanced through the binding and release of silver nanoparticles [212] and the antibacterial drug ciprofloxacin hydrochloride [86] .
When used synergistically, ES and CPs have been shown to activate dermal fibroblasts and promote the expression of TGFβ 1 and other key factors that drive cell proliferation, differentiation, inflammation response, keratinocyte migration and extra-cellular matrix production [216] . Human dermal fibroblasts cultured on PPy-PDLLA composite membranes displayed enhanced proliferation when stimulated with a direct current [217] . Comparably, ES delivered through nanofibres of PANI blended with PLLA-co-PCL was observed to increase the growth and adhesion of NIH-3T3 fibroblasts [218] . Stimulating human skin fibroblasts on PPy/PLLA membranes resulted in greater viability and mitochondrial activity [219] . A tenfold increase in the secretion of interleukin-6 and interleukin-8, two cytokines important for wound repair and the growth of new blood vessels, was reported when exposing skin fibroblasts on conductive PPy and degradable PLLA composite scaffolds to an electrical stimulus [220] . The delivery of ES through conductive polymers can be useful for the formation of new blood vessels: human umbilical vein endothelial cells stimulated with 200-400 mV/cm on PANI-coated PCL fibres exhibited highly enhanced viability and adhesion [221] . Subjecting PC12 nerve cells to ES through PPy scaffolds resulted in the formation of greater numbers of longer neurites [222, 223] . Nerve stem cells displayed a similar behaviour, extending more neurites when stimulated on a PLLA/PANI scaffold [223] , and enhanced proliferation and neurite outgrowth on PANI-PCL/gelatin substrates [224] . ES and conductive scaffolds have been combined with stem cell based therapies: the pre-stimulation of human neural progenitor cells on PPy scaffolds before transplantation improved functional outcomes in rat stroke models [225] . Bone formation was successfully promoted by stimulating rat bone marrow stromal cells on PPy films; resulting in the up-regulation of osteogenic markers, accelerated cell differentiation, and improved calcium deposition and matrix mineralization [226] . The delivery of 200 μA of direct current for 4 h for 21 days increased the calcium deposition by 100% in human adiposederived mesenchymal stem cells cultured on PPy-PCL substrates [227] . Similarly, marrow stromal cells and MC3T3-E1 pre-osteoblast cells displayed significantly increased mineralisation when stimulated on self-doped sulfonated polyaniline (SPAN)-based electrodes [228] .
The piezoelectric mechanism in tissue regeneration
As previously stated, ES therapy has been well established as an important cue for enhancing the process of wound healing in different tissues [229, 230] by governing cellular behaviour and tissue response. Piezoelectric materials in the form of scaffolds and NPs (Fig. 11) have been used to administer this cue efficiently to cells with great therapeutic potential in treating cancer, bone injures and neural disorders [37, 40, [231] [232] [233] [234] [235] [236] .
Piezoelectric polymers as nerve guidance channels were reported by Aebischer et al. in the late 20th century [237] [238] [239] . Compelling in vivo results obtained by use of PVDF and its copolymers in these studies affirmed the role of electrical charges in the process of nerve repair. However, research in the following years was more focused on deciphering the mechanisms through which electrical stimulation influences nerve cell behaviour [240, 241] . The field has gathered growing interest of the scientific community in the last few years. To this regard, BN, ZO and BT piezoelectric nanomaterials that have been fabricated in various forms including: nanotubes, nanowires and nanospheres, providing greater surface area to volume ratio for better cell-material interactions [242, 243] . BNNTs and BTNPs have shown promising results for wireless neuronal stimulation. For instance, Ciofani et al. used BNNTs and BTNPs in two different studies using different neuronal like cell lines [234, 244] . The piezoelectric nanomaterials stimulated by ultrasound generated potentials in the range of 0.07 to 0.19 mV [244] that contributed to greater neurite sprouts by a 30-fold increase compared to the controls Fig. 11 . Examples of different piezoelectric based scaffolds.
after treatment [234] . Other than piezoelectric nanoparticle systems, scaffolds based on piezoelectric materials have been explored for nerve regeneration [235, [244] [245] [246] [247] [248] [249] . In a series of studies by Lee et al., electrospun piezoelectric membranes of PVDF-TrFE were fabricated and different cell lines were tested for neuroregenration capability [247, 250, 251] . The effect of fibre alignment and piezoelectricity on neurite extension of dorsal root ganglion neurons was assessed, and it was reported that cell growth and neurite extension was well-supported by annealed and aligned fibres that also exhibited the greatest piezoelectric effect [247] . These results were confirmed by another study which reported that PVDF electrospun scaffolds with controlled alignment and physical properties were best suited for survival and differentiation of monkey neural stem cells [249] . Both in vivo and in vitro results obtained were supportive of the use of piezoelectric conduits for repairing nerve injuries [247, 250, 251] . Unlike these studies in which the initiation of the piezoelectric mechanism of the scaffold relies on the cellular interactions and natural animal movements, several studies have reported on externally simulating the effect using ultrasound or vibrating waves [245, 246, 252] . Piezoelectric electrospun PVDF and BTNPs nanocomposite membranes with and without external mechanical stimulation have also been studied in recent years for nerve tissue engineering applications [248, 253] .
Similar studies conducted by Ciofani et al. with BNNTs and BTNPs enhanced gene expression and cytokine production by stimulating osteoblasts, myoblasts and fibroblasts in comparison to controls [232, 233, 236, 254] . However, such non-invasive techniques using piezoelectric nanoparticles to deliver the electrical therapy to wounds and injuries is relatively new and requires extensive research before clinical applications are approved [235] .
Piezoelectric scaffolds have been used as wound patches for dermal injuries to electrically stimulate the injury site ensuring enhanced recovery through improved cellular response. The presence of piezo receptors on cells and their role in controlling cell behaviour to enhance wound healing corroborates the use of piezoelectrics to stimulate cell response [255, 256] . The piezo receptors on cells are activated when cells undergo mechanical deformation in response to an injury or otherwise, this deformation activates ionic channels consequently leading to generation of electrical signals which assist in intracellular signalling and hold great physiological importance [255, 256] . A study by Ying et al. focused on exploiting the piezoelectric property of PVDF electrospun scaffolds blended with polyurethane (PU) for treatment of skin wounds [257] . These were deformed in a controlled manner, and enhanced migration (to the scratched area of scaffolds in a wound healing assay) and adhesion of fibroblasts were observed when compared to non-deformed samples [257] . A more recent study published in 2017 by Bhang et al. reported ZO based piezoelectric dermal patches [258] . The study included in vitro and in vivo results supporting the promotion of wound healing through generation of optimum levels of electric potentials ranging from 300 to 900 mV. These electric potentials enhanced dermal fibroblast activity and lead to the upregulation of biochemical factors such as CD68 protein and vascular endothelial growth factor contributing towards improved wound healing [258] . Tan et al. observed that potassium sodium niobate (KNN) based piezo ceramics show surface selective antibacterial activity [259] . They observed that reactive oxygen species (ROS) were formed around the piezoelectric ceramic surfaces as a result of microelectrolytic activity. The formation of ROS around the cathode surface was higher and led to significant antibacterial activity, while the ROS levels generated remaining safe for mammalian cells. This study suggests that inherently antibacterial scaffolds can also be manufactured using piezoelectric materials.
The most prominent use of piezoelectric materials as scaffolds has been found in the field of bone tissue engineering [36, 37] . Use of piezoelectric materials for bone repair application ensures that the electrical stimulation therapy is delivered to the injury area effectively. Piezoelectric materials are capable of restoring the electrical microenvironment around the injury site and can generate electrical signals which can alter cellular behaviour [148, 260] . Piezoelectric polymers such as PVDF, PVDF-TrFE, PLLA, PHB alongside piezoelectric ceramics including BT, LN, LNKN, HA have been assessed for their osteogenic capability [36, 37, 147] . In particular, the last two years have seen a rise in the number of publications in this area and the promising results obtained point towards a clinical solution to the problem of orthopaedic regeneration [147, 148, 231, [261] [262] [263] [264] [265] .
Control over the amount of electrical stimulation delivered by nanoparticles or scaffolds has been established by controlling the uptake of NPs by cells (specific amount of NPs), or a material with optimized piezoelectric characteristics to generate physiological levels of potentials in response to deformation. To mechanically stimulate the piezoelectric materials in vitro and consequently study the effect of piezo characteristics on drug release, different strategies such as deformable cell culture plates or ultrasound should be utilized, while in the case of scaffolds implanted in vivo, the same can achieved through the natural movement of the animal. It must be noted that different stimulation mechanisms such as ultrasound, bending and others are capable of inducing different responses and the choice of methodology should depend on the type of application desired.
Electrets as exogenous stimulators for wound healing
Other than the use of electrets as transdermal delivery of drugs, electrets have been found useful as exogenous electrical stimulators in terms of wound healing in several tissues such as bone and skin [266] . The first studies on the use of electrets for healing of dermal wounds dates back to the 1990s [151] . In an in vivo study conducted in pigs, it was found that the treatment of skin wounds using PTFE electrets enhanced the growth of epithelial cells and accelerated the process of wound healing [151] . Though the results obtained in this study were compelling, there has not been considerable amount of research for fabricating electret based wound dressings. On the other hand, HA based electrets have gathered significant attention in the past decade, not only for skin but also for bone tissue engineering [266] [267] [268] [269] . Nakamura et al. fabricated wound dressings based on silk fibroin and HA electrets and tested their dermal healing capability in vitro and in vivo [270, 271] . It was observed that cellular migration and angiogenesis was promoted by the presence of charged HA in wound dressings. Chitosan and HA based electret membranes have also been reported for bone healing applications [268, 272] . While chitosan electrets show stable surface charges [273, 274] , HA electrets have exhibited accelerated bone bonding rate and osteogenic gene expression in vivo [275] [276] [277] . In this regard, Qu et al. showed that heat treated chitosan electrets showed superior charge storage stability, with in vivo studies exhibiting their enhanced osteogenic potential as guided bone regeneration membranes [272] . In a similar study by the same group, the relatively poor mechanical properties of chitosan were enhanced with negatively charged HA into a composite electret membrane [268] . Their results showed that electret composite membranes based on chitosan and HA could promote osteoblast proliferation and differentiation in vitro, with potential clinical applications as a new strategy for such electret based scaffolds. The nerve healing potential of electrically charged electrets have also been reported on poled PVDF [238, 278] , PTFE [279] and PLGA [280] polymers in the form of film conduit scaffolds, suggesting the potential of electret guides prepared by electrical poling for peripheral nerve regeneration.
Photovoltaic mediated tissue response
Strategies are emerging for the use of photovoltaic-based materials as carriers of electrical stimuli for tissue regeneration. For instance, in 2015 Lorach et al. demonstrated that subretinal array implants with 70 μm-wide photovoltaic pixels were able to provide highly localized stimulation to retinal neurons in rats, and that the electrical receptive fields recorded were similar in size to the natural visual receptive ones [281] . This opens up the possibility to using photovoltaic arrays as functional restoration wireless devices that can safely elicit and modulate cellular responses, not only on the retina [282] [283] [284] but on other tissues as well [285] . A similar strategy can be envisioned to facilitate wound healing rates [286, 287] , which may serve as a promising modality for controlling and treating various skin diseases and disorders. To this regard, the usefulness of delivering specific electrical signals for enhanced wound healing is demonstrated by its ability to induce re-epithelization of skin wounds by enhancing angiogenesis, blocking edema formation or promoting migration and proliferation of various skin cells (i.e. fibroblasts, keratinocytes and epithelial cells) [186] [187] [188] . Photovoltaic based materials such as poly(3-hexylthiophene)-phenyl-C61-butyric acid methyl ester (P3HT-PCBM) have also been proposed as optical modulators of cellular activity based on their photothermal effect upon light stimulation [288] . Light absorption generates different photo-excited states in the material that release thermal energy into the living cells of the environment, and such photoexcitation could be useful into developing new platforms for cell control by light to promote wound healing [289] [290] [291] . To this regard, electrospun photovoltaic based P3HT/PCL fibres were shown to significantly increased proliferation, extracellular matrix secretion and favour cell morphology of fibroblasts into the characteristic spindle shape upon light stimulation in vitro using white light-emitting diodes within the range of visible light (390-750 nm) [292] .
Future perspectives on the use of electroactive biomaterials in drug delivery and tissue regeneration
Future CP-based drug delivery systems will see the use of biodegradable variants of CPs [124, 125] that degrade at the end of their useful lifetime and clear from the patient's body without the need for removal surgery. Such polymers have already been developed by combining polypyrrole-thiophene (PPy-PTh) [293] or quaterthiophene [294] with degradable ester linkages. New CP materials will be created to become more resilient to the structural damage and conductivity loss caused by repeated redox switching. A good example of one such promising material is poly(3,4-alkylenedioxypyrrole) (PXDOP) [295] . Novel approaches based on the co-delivery of multiple medicinal compounds, injectable CP microcapsules, or micro-and nano-porous structures are currently of great interest and will see wider application [14, 296, 297] . Also of great interest are CP based drug delivery systems that are selfregulating, i.e. release drug compounds in response to changes in mechanical, biological chemical and/or electrical conditions in their vicinity, without the need for an external power source, and will likely be developed in the future [14, 66] .
The area of piezoelectric polymers and ceramics for tissue engineering applications has been researched extensively in the last decade [37] , and they have shown great potential for use in the field of controlled therapeutics. The capabilities of these materials for delivery of electric cues and essential drugs to the damaged wound have been studied independently. However, the correlation between the two processes and the mechanism through which the release of drugs can be affected due to the piezoelectric characteristics (varying surface charge and potential of the material) remains to be explored. While significant progress has been made towards improving wound healing, the current research in the area is focused on the use of synthetic polymers or ceramics, and there is recent interest in developing piezoelectric hydrogels and controlled (bio)degradable piezoelectrics [298] [299] [300] . There is a need for developing strategies for loading piezoelectric materials with different hydrophobic and hydrophilic drugs and studying their release kinetics in vitro and in vivo. The challenge is to fabricate a smart bio-active scaffold with combined capability. A drug-loaded piezoelectric scaffold with tuneable release of drug or composites based on piezomaterials might be utilized for this purpose. Emerging strategies are focused on developing bioreactors to mimic in vivo conditions and explore the mechanical stimulation of the material to provide suitable electric cues and drug profile release before these therapies can be translated from the bench to the market. A new generation of bioreactors is needed to achieve a deep knowledge of the transduction effects of these materials on specific cells. Indeed, piezoelectric characteristics of different biological systems and biomaterials have been studied using piezoresponse force microscopy (PFM) [301, 304] , a technique to study the material characteristics at the nanoscale and obtain a better understanding of the mechanisms by which the physiological processes are affected [303] . Nevertheless, as discussed in this review, piezoelectric materials have independently been used for delivery of drugs or electrical stimulation of cells and tissues, and amalgamating these two approaches is promising.
There is limited literature on the use of electrets for dermal, bone and neural healing applications, and considerable amount of research is still required to confirm their usage for TDD or wound dressings. Though these materials have been found useful for TDD, there has been little mention of how the release behaviour of specific drugs can be controlled. Some electrets also possess piezo properties [304] , however, their combined role on release behaviour of drugs is still to be explored. Combining their capability for TDD and altering cellular behaviour is a promising area of research. Electrets also present unique capability of being used for fabrication of smart electronic skins [305] , and while the typical format is in the form of films, there is significant research scope for developing novel electret hydrogel dressings. However, the ability to permanently store charges on these other formats might pose challenging.
PV-based devices present significant challenge in preparing assemblies of particles that result in continuous but separate conduction paths for electrons and holes [306] , and further formulation optimization is required to improve efficiency of light entrapment in these devices. For instance, surface plasmon resonance, metal-particle scattering and surface structuring techniques have been studied as new alternatives to enhance light trapping in PV devices [307] [308] [309] . On the other hand, most PV systems to date come in the format of films [53] , which is useful for wound dressings. PV systems in the form of gels and hydrogels have been developed as well [310] . However, these systems should also be developed towards other formats such as porous sponges, fibres, rods or spherical structures [49, 311] for the purpose of facilitating drug delivery at the wound site. To this regard, Labastide et al. have envisioned organizing n-type and p-type moieties into separate spherical nanoparticles and arranging them into stable superlattices whose structure is defined by the nanoparticle radii [306] . Further research on PV-based MOFs should be carried out; existing systems have proven poor performances and their capability as photovoltaic based delivery carriers for wound healing has not been tested yet. Extensive research towards attaching and releasing drugs or other therapeutics from PV cells in the most efficient way is needed both in vitro and in vivo clinical applications before this technology can be translated from the bench to the market. Another issue to bear in mind is degradability and cytotoxicity of the existing PV materials. In this sense, surface modification is a factor to take into account for enhanced delivery efficiency, and pharmacokinetics of the therapeutic loaded PV based device is an important step that demands full investigation to estimate their actual performance. Although important improvements need to be taken care of before clinical applications are a reality, there might be a bright future in their application as delivery systems for wound treatment.
Conclusions
Controlled delivery of drugs and electrical stimulation are promising approaches for enhanced wound healing of damaged tissues, which are well demonstrated by conductive polymers, electrets, piezoelectric and photovoltaic based materials. The capability of conductive polymers and piezoelectrics as multi-tasking scaffolds is well supported by the encouraging results presented, while electrets and photovoltaics are still new to the field of research. Electroactive biomaterials have been found useful for treating injuries to tissues such as skin, bone and nerve. However, clinical translation for wound healing is achievable after thorough attempts are made to overcome the limitations presented by individual systems. There is a need to amalgamate different electroactive systems, such as piezoelectrics and CPs to eliminate the need of an external stimulation device to attain desired outcomes.
The field of electroactive biomaterials for release of therapeutic agents is growing. There are challenges and limitations in the translation of these new therapeutic approaches that remain to be answered, such as safety, cost, and efficacy of treatment and degradability of the material. It is safe to predict that as our understanding of electroactive materials improves along with technological advancements in scaffold fabrication, therapeutic encapsulation and drug release, the near future will see electroactive based techniques become a standard practice for wound regeneration.
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